Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Nuvelo reveals alfimeprase program progress in 2002

Feb. 27, 2003

New PAI-1 inhibitors in early development at Tanabe Seiyaku

Feb. 27, 2003

Encouraging results obtained for Exanta in prevention of stroke in atrial fibrillation

Feb. 20, 2003

Merck designs new factor Xa and/or factor VIIa inhibitors

Feb. 20, 2003

Aventis claims novel factor VIIa inhibitors

Feb. 19, 2003

Dual TXA2/5-HT2 antagonists prepared and tested by Servier research team

Feb. 17, 2003

Eptacog alfa in intracerebral hemorrhage

Feb. 13, 2003

Wyeth presents various series of PAI-1 inhibitors

Feb. 11, 2003

Design and synthesis of potent and selective direct thrombin inhibitors

Feb. 10, 2003

ZymoGenetics initiates rFXIII phase I trials, signs exclusive licensing agreement

Feb. 7, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...